Roz L - Search Results

1

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Pereira C, Gimenez-Xavier P, Pros E, Pajares MJ, Moro M, Gomez A, Navarro A, Condom E, Moran S, Gomez-Lopez G, Graña O, Rubio-Camarillo M, Martinez-Martí A, Yokota J, Carretero J, Galbis JM, Nadal E, Pisano D, Sozzi G, Felip E, Montuenga LM, Roz L, Villanueva A, Sanchez-Cespedes M. Pereira C, et al. Among authors: roz l. Clin Cancer Res. 2017 Jun 15;23(12):3203-3213. doi: 10.1158/1078-0432.CCR-16-1946. Epub 2017 Mar 16. Clin Cancer Res. 2017. PMID: 28302866

2

Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.

Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA, Tavecchio L. Sozzi G, et al. Among authors: roz l. Cancer Res. 2001 Jun 15;61(12):4675-8. Cancer Res. 2001. PMID: 11406535

3

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines.

Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G. Roz L, et al. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3615-20. doi: 10.1073/pnas.062030799. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891319 Free PMC article.

4

Involvement of FHIT in lung carcinogenesis prospects for future clinical gene therapy applications.

Sozzi G, Andriani F, Gramegna M, Roz L. Sozzi G, et al. Among authors: roz l. Suppl Tumori. 2002 Jul-Aug;1(4):S62. Suppl Tumori. 2002. PMID: 12415825 Review. No abstract available.

5

Quantification of free circulating DNA as a diagnostic marker in lung cancer.

Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U. Sozzi G, et al. Among authors: roz l, roz e. J Clin Oncol. 2003 Nov 1;21(21):3902-8. doi: 10.1200/JCO.2003.02.006. Epub 2003 Sep 24. J Clin Oncol. 2003. PMID: 14507943

6

Detecting lung cancer in plasma with the use of multiple genetic markers.

Andriani F, Conte D, Mastrangelo T, Leon M, Ratcliffe C, Roz L, Pelosi G, Goldstraw P, Sozzi G, Pastorino U. Andriani F, et al. Among authors: roz l. Int J Cancer. 2004 Jan 1;108(1):91-6. doi: 10.1002/ijc.11510. Int J Cancer. 2004. PMID: 14618621 Free article.

7

The apoptotic pathway triggered by the Fhit protein in lung cancer cell lines is not affected by Bcl-2 or Bcl-x(L) overexpression.

Roz L, Andriani F, Ferreira CG, Giaccone G, Sozzi G. Roz L, et al. Oncogene. 2004 Dec 2;23(56):9102-10. doi: 10.1038/sj.onc.1208142. Oncogene. 2004. PMID: 15489891

8

Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer.

Nonaka D, Fabbri A, Roz L, Mariani L, Vecchione A, Moore GW, Tavecchio L, Croce CM, Sozzi G. Nonaka D, et al. Among authors: roz l. Cancer Res. 2005 Feb 15;65(4):1207-12. doi: 10.1158/0008-5472.CAN-04-3461. Cancer Res. 2005. PMID: 15735004 Free article.

9

Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.

Cirincione R, Lintas C, Conte D, Mariani L, Roz L, Vignola AM, Pastorino U, Sozzi G. Cirincione R, et al. Among authors: roz l. Int J Cancer. 2006 Mar 1;118(5):1248-53. doi: 10.1002/ijc.21473. Int J Cancer. 2006. PMID: 16152615 Free article.

10

Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.

Sozzi G, Roz L, Conte D, Mariani L, Andriani F, Verderio P, Pastorino U. Sozzi G, et al. Among authors: roz l. J Natl Cancer Inst. 2005 Dec 21;97(24):1848-50. doi: 10.1093/jnci/dji432. J Natl Cancer Inst. 2005. PMID: 16368947

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page